MedTrace Logo

Propranolol for Treating Fibromyalgia Pain

NCT03029845 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2018-08-23

No results posted yet for this study

Summary

The purpose of the study to evaluate the feasibility of using low dose propranolol for people with fibromyalgia.

Conditions

  • Fibromyalgia Pain

Interventions

DRUG

Propranolol 1

Participants will take 20 mg propranolol twice a day for 2 weeks

DRUG

Propranolol 2

Participants will take 10 mg propranolol twice a day for 2 weeks

DRUG

Placebo

Participants will take placebo twice a day for 2 weeks

Sponsors & Collaborators

Principal Investigators

  • Akiko Okifuji, PhD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-04-30
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03029845 on ClinicalTrials.gov